CNP mediated selective toxicity on melanoma cells is accompanied by mitochondrial dysfunction

Area of Science:

• Nanomedicine
• Biochemistry
• Oncology

Background:

• Cerium oxide nanoparticles (CNP) exhibit selective cytotoxicity towards cancer cells.
• CNP possess redox-active properties, acting as prooxidants in cancer cells and antioxidants in normal cells.
• Malignant melanoma is an aggressive skin cancer with poor prognosis, especially when metastatic.

Purpose of the Study:

• To investigate the mechanisms underlying the prooxidative effects of CNP in metastatic human melanoma cells.
• To elucidate the role of mitochondria in CNP-induced cancer cell death.

Main Methods:

• Treatment of A375 melanoma cells and melanocytes with CNP.
• Measurement of intracellular reactive oxygen species (ROS) levels.
• Assessment of mitochondrial function, including bioenergetics, dynamics, and morphology.
• Evaluation of CNP-induced cell death and its modulation by PEG-conjugated catalase.

Main Results:

• CNP selectively increased mitochondrial ROS levels in melanoma cells.
• Mitochondrial thiol oxidation and dysfunction, including altered bioenergetics and cristae morphology, were observed.
• CNP-induced cell death was significantly reduced by catalase, indicating a role for hydrogen peroxide.

Conclusions:

• Cerium oxide nanoparticles induce cell death in metastatic melanoma cells primarily through mitochondrial dysfunction.
• Hydrogen peroxide production linked to mitochondrial impairment is a key mechanism of CNP cytotoxicity.
• CNP demonstrate potential as a targeted therapeutic agent for melanoma, sparing healthy cells.